COLYN WRIGHT: Open Payments
NPI 1477207280 · DANVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,367 in 117 payments from 21 companies in 2025. Trend: 2023 $2,411 · 2024 $2,192 · 2025 $2,367
Food & beverage: $2,367
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $525 |
| Madrigal Pharmaceuticals | 12 | $329 |
| Ardelyx, Inc. | 11 | $241 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $188 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $181 |
| EVOKE PHARMA, INC. | 1 | $120 |
| Gilead Sciences, Inc. | 4 | $108 |
| GENZYME CORPORATION | 5 | $103 |
| QOL Medical, LLC | 4 | $98 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
Products named: REZDIFFRA, IBSRELA, RINVOQ, DUPIXENT, XIFAXAN, ENTYVIO, LINZESS, Sucraid.
Industry payments across KY — which companies pay providers there.
